Literature DB >> 23886740

Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome.

Y Kaichi1, S Kakeda, J Moriya, N Ohnari, K Saito, Y Tanaka, F Tatsugami, S Date, K Awai, Y Korogi.   

Abstract

BACKGROUND AND
PURPOSE: Antiphospholipid syndrome may affect the incidence and pathogenesis of cerebrovascular diseases in patients with systemic lupus erythematosus. We compared the spectrum of MR findings in patients with systemic lupus erythematosus with and without antiphospholipid syndrome.
MATERIALS AND METHODS: We identified 256 patients with systemic lupus erythematosus (45 with, 211 without antiphospholipid syndrome) who underwent MR studies; in 145 (57%), we detected abnormalities. These were categorized as large territorial, lacunar, localized cortical, and borderzone infarctions and as microembolisms, basal ganglia lesions, callosal lesions, hemorrhages, and white matter hyperintensity on T2-weighted and/or FLAIR images, and as stenotic arterial lesions on MR angiograms. Logistic regression analysis was performed to compare the MR findings in patients with systemic lupus erythematosus with and without antiphospholipid syndrome, with patient age and antiphospholipid syndrome as the covariates.
RESULTS: Abnormal MR findings were more common in patients with systemic lupus erythematosus with antiphospholipid syndrome (73% versus 53%). Large territorial (P = .01), lacunar (P = .01), localized cortical (P < .01), borderzone infarcts (P < .01), basal ganglia lesions (P = .03), stenotic arterial lesions (P = .04), and the rate of positive findings on MR imaging (P = .01) were significantly associated with antiphospholipid syndrome. Irrespective of age, significantly more patients with antiphospholipid syndrome manifested lacunar infarcts in the deep white matter (P < .01), localized cortical infarcts in the territory of the MCA (P < .01), bilateral borderzone infarcts (P < .01), and anterior basal ganglia lesions (P = .01).
CONCLUSIONS: Abnormal MR findings were more common in patients with systemic lupus erythematosus with than in those without antiphospholipid syndrome. Large territorial infarctions, lacunar infarctions in the deep white matter, localized cortical infarctions in the MCA territory, bilateral borderzone infarctions, anterior basal ganglia lesions, and stenotic arterial lesions are common MR findings in patients with systemic lupus erythematosus with antiphospholipid syndrome.

Entities:  

Mesh:

Year:  2013        PMID: 23886740      PMCID: PMC7966497          DOI: 10.3174/ajnr.A3645

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.

Authors:  G K Bertsias; J P A Ioannidis; M Aringer; E Bollen; S Bombardieri; I N Bruce; R Cervera; M Dalakas; A Doria; J G Hanly; T W J Huizinga; D Isenberg; C Kallenberg; J C Piette; M Schneider; N Scolding; J Smolen; A Stara; I Tassiulas; M Tektonidou; A Tincani; M A van Buchem; R van Vollenhoven; M Ward; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

3.  The morphologic correlate of incidental punctate white matter hyperintensities on MR images.

Authors:  F Fazekas; R Kleinert; H Offenbacher; F Payer; R Schmidt; G Kleinert; H Radner; H Lechner
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

Review 4.  Lacunar strokes and infarcts: a review.

Authors:  C M Fisher
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

5.  Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.

Authors:  E Hachulla; U Michon-Pasturel; D Leys; J P Pruvo; V Queyrel; E Masy; J Arvieux; C Caron; F Brevet-Coupé; P Y Hatron; B Devulder
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  Severe hemodynamic impairment and border zone--region infarction.

Authors:  C P Derdeyn; A Khosla; T O Videen; S M Fritsch; D L Carpenter; R L Grubb; W J Powers
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

7.  Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients.

Authors:  J H Kim; C G Choi; S J Choi; H K Lee; D C Suh
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

8.  Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.

Authors:  A Sabet; W L Sibbitt; C A Stidley; J Danska; W M Brooks
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

9.  A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

Authors:  D Karussis; R R Leker; A Ashkenazi; O Abramsky
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

10.  Cerebral changes in SLE with or without antiphospholipid syndrome. a case-control MRI study.

Authors:  Sergio I Valdés-Ferrer; Felipe Vega; Carlos Cantú-Brito; Joel Ceballos-Ceballos; Bruno Estañol; Gullermo García-Ramos; Antonio R Cabral
Journal:  J Neuroimaging       Date:  2008-01       Impact factor: 2.486

View more
  7 in total

1.  Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus.

Authors:  Pamela Munguía-Realpozo; Mario García-Carrasco; Claudia Mendoza-Pinto; María de Lourdes Galaviz-Silva; Ivet Etchegaray-Morales; Socorro Méndez-Martínez; Álvaro José Montiel-Jarquín; Luis G Vázquez de Lara; Luis H Silveira
Journal:  Clin Rheumatol       Date:  2022-05-27       Impact factor: 3.650

2.  Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping.

Authors:  Mari Miyata; Shingo Kakeda; Kohsuke Kudo; Shigeru Iwata; Yoshiya Tanaka; Yi Wang; Yukunori Korogi
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-16       Impact factor: 6.200

3.  Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort.

Authors:  C Magro-Checa; S Kumar; S Ramiro; L J Beaart-van de Voorde; J Eikenboom; I Ronen; J de Bresser; M A van Buchem; T W Huizinga; G M Steup-Beekman
Journal:  Lupus       Date:  2018-12-08       Impact factor: 2.911

Review 4.  Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus.

Authors:  Meggan Mackay; Chris C Tang; An Vo
Journal:  Curr Opin Neurol       Date:  2020-06       Impact factor: 5.710

5.  White Matter Hyperintensities as a Risk Factor for Ischemic Stroke in Patients With Systemic Lupus Erythematosus.

Authors:  Eri Sano; Shigeki Arawaka
Journal:  Front Neurol       Date:  2021-12-13       Impact factor: 4.003

6.  Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus.

Authors:  Mari Miyata; Shingo Kakeda; Shigeru Iwata; Shingo Nakayamada; Satoru Ide; Keita Watanabe; Junji Moriya; Yoshiya Tanaka; Yukunori Korogi
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

7.  Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.

Authors:  Claire Donnellan; Hannah Cohen; David J Werring
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.